Comparison of platelet-rich plasma formulations for cartilage healing: An in vitro study

Journal of Bone and Joint Surgery

Volumn 96, Issue 5, 2014, Pages 423-429

  Cavallo, Carola ^a   Filardo, Giuseppe ^a   Mariani, Erminia ^a   Kon, Elizaveta ^a   Marcacci, Maurilio ^a   Pereira Ruiz, Maria Teresa ^b   Facchini, Andrea ^a   Grigolo, Brunella ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b Policlinico Italia Private Clinic   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; COLLAGEN TYPE 2; GROWTH FACTOR; HYALURONIC ACID; HYALURONIC ACID SYNTHASE 2; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LUBRICIN; MATRIX METALLOPROTEINASE; PLATELET DERIVED GROWTH FACTOR AB; PLATELET DERIVED GROWTH FACTOR BB; THROMBOCYTE CONCENTRATE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

AGED; ARTICLE; BIOSYNTHESIS; CARTILAGE CELL; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; DRUG FORMULATION; GENE EXPRESSION; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; LEUKOCYTE; LEUKOCYTE PLATELET RICH PLASMA; MALE; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE POOR PLASMA; THROMBOCYTE RICH PLASMA;

ADULT; CARTILAGE; CHONDROCYTES; HUMANS; MALE; PLATELET-RICH PLASMA; WOUND HEALING;

EID: 84896369299     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.M.00726     Document Type: Article

References (57)

1. Buckwalter JA. Articular cartilage: injuries and potential for healing. J Orthop Sports Phys Ther. 1998 Oct;28 (4):192-202.
2. Marcacci M, Filardo G, Kon E. Treatment of cartilage lesions: what works and why? Injury. 2013 Jan;44 (Suppl 1):S11-5.
3. Kon E, Filardo G, Drobnic M, Madry H, Jelic M, van Dijk N, Della Villa S. Non-surgical management of early knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2012 Mar;20 (3):436-49. Epub 2011 Oct 25.
4. Gomoll AH, Filardo G, de Girolamo L, Espregueira-Mendes J, Marcacci M, Rodkey WG, Steadman JR, Zaffagnini S, Kon E. Surgical treatment for early osteoarthritis. Part I: cartilage repair procedures. Knee Surg Sports Traumatol Arthrosc. 2012 Mar; 20 (3):450-66. Epub 2011 Nov 24.
5. Gomoll AH, Filardo G, Almqvist FK, Bugbee WD, Jelic M, Monllau JC, Puddu G, Rodkey WG, Verdonk P, Verdonk R, Zaffagnini S, Marcacci M. Surgical treatment for early osteoarthritis. Part II: allografts and concurrent procedures. Knee Surg Sports Traumatol Arthrosc. 2012 Mar;20 (3):468-86. Epub 2011 Nov 09.
6. Filardo G, Kon E, Di Martino A, Iacono F, Marcacci M. Arthroscopic secondgeneration autologous chondrocyte implantation: a prospective 7-year follow-up study. Am J Sports Med. 2011 Oct;39 (10):2153-60. Epub 2011 Jul 29.
7. Kon E, Filardo G, Berruto M, Benazzo F, Zanon G, Della Villa S, MarcacciM. Articular cartilage treatment in high-level male soccer players: a prospective comparative study of arthroscopic second-generation autologous chondrocyte implantation versus microfracture. Am J Sports Med. 2011 Dec;39 (12):2549-57. Epub 2011 Sep 07.
8. Della Villa S, Kon E, Filardo G, Ricci M, Vincentelli F, Delcogliano M, Marcacci M. Does intensive rehabilitation permit early return to sport without compromising the clinical outcome after arthroscopic autologous chondrocyte implantation in highly competitive athletes? Am J Sports Med. 2010 Jan;38 (1):68-77.
9. Filardo G, Vannini F, Marcacci M, Andriolo L, Ferruzzi A, Giannini S, Kon E. Matrixassisted autologous chondrocyte transplantation for cartilage regeneration in osteoarthritic knees: results and failures at midterm follow-up. Am J Sports Med. 2013 Jan;41 (1):95-100. Epub 2012 Oct 25.
10. Filardo G, Kon E, Di Martino A, Patella S, Altadonna G, Balboni F, Bragonzoni L, Visani A, Marcacci M. Second-generation arthroscopic autologous chondrocyte implantation for the treatment of degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc. 2012 Sep;20 (9):1704-13. Epub 2011 Nov 01.
11. Kon E, Filardo G, Condello V, Collarile M, Di Martino A, Zorzi C, Marcacci M. Second-generation autologous chondrocyte implantation: results in patients older than 40 years. Am J Sports Med. 2011 Aug;39 (8):1668-75. Epub 2011 May 19.
12. Frazer A, Bunning RA, Thavarajah M, Seid JM, Russell RG. Studies on type II collagen and aggrecan production in human articular chondrocytes in vitro and effects of transforming growth factor-beta and interleukin-1beta. Osteoarthritis Cartilage. 1994 Dec;2 (4):235-45.
13. Pujol JP, Chadjichristos C, Legendre F, Bauge C, Beauchef G, Andriamanalijaona R, Galera P, Boumediene K. Interleukin-1 and transforming growth factor-beta 1 as crucial factors in osteoarthritic cartilage metabolism. Connect Tissue Res. 2008;49 (3):293-7.
14. Schmidt MB, Chen EH, Lynch SE. A review of the effects of insulin-like growth factor and platelet derived growth factor on in vivo cartilage healing and repair. Osteoarthritis Cartilage. 2006 May;14 (5):403-12. Epub 2006 Jan 18.
15. Martin JA, Buckwalter JA. The role of chondrocyte-matrix interactions in maintaining and repairing articular cartilage. Biorheology. 2000;37 (1-2):129-40.
16. O'Keefe RJ, Crabb ID, Puzas JE, Rosier RN. Effects of transforming growth factorbeta 1 and fibroblast growth factor on DNA synthesis in growth plate chondrocytes are enhanced by insulin-like growth factor-I. J Orthop Res. 1994 May;12 (3):299-310.
17. Cole BJ, Seroyer ST, Filardo G, Bajaj S, Fortier LA. Platelet-rich plasma: where are we now and where are we going? Sports Health. 2010 May;2 (3):203-10.
18. Kon E, Filardo G, Di Martino A, Marcacci M. Platelet-rich plasma (PRP) to treat sports injuries: evidence to support its use. Knee Surg Sports Traumatol Arthrosc. 2011 Apr;19 (4):516-27. Epub 2010 Nov 17.
19. Tschon M, Fini M, Giardino R, Filardo G, Dallari D, Torricelli P, Martini L, Giavaresi G, Kon E, Maltarello MC, Nicolini A, Carpi A. Lights and shadows concerning platelet products for musculoskeletal regeneration. Front Biosci (Elite Ed). 2011 Jan 1;3:96-107.
20. Sánchez AR, Sheridan PJ, Kupp LI. Is platelet-rich plasma the perfect enhancement factor? A current review. Int J Oral Maxillofac Implants. 2003 Jan-Feb;18 (1):93-103.
21. Sánchez M, Anitua E, Azofra J, Aguirre JJ, Andia I. Intra-articular injection of an autologous preparation rich in growth factors for the treatment of knee OA: a retrospective cohort study. Clin Exp Rheumatol. 2008 Sep-Oct;26 (5):910-3.
22. Sampson S, Reed M, Silvers H, Meng M, Mandelbaum B. Injection of plateletrich plasma in patients with primary and secondary knee osteoarthritis: a pilot study. Am J Phys Med Rehabil. 2010 Dec;89 (12):961-9.
23. Wang-Saegusa A, Cugat R, Ares O, Seijas R, Cuscó X, Garcia-Balletbó M. Infiltration of plasma rich in growth factors for osteoarthritis of the knee short-term effects on function and quality of life. Arch Orthop Trauma Surg. 2011 Mar;131 (3):311-7. Epub 2010 Aug 17.
24. Filardo G, Kon E, Buda R, Timoncini A, Di Martino A, Cenacchi A, Fornasari PM, Giannini S, Marcacci M. Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2011 Apr;19 (4):528-35. Epub 2010 Aug 26.
25. Napolitano M, Matera S, Bossio M, Crescibene A, Costabile E, Almolla J, Almolla H, Togo F, Giannuzzi C, Guido G. Autologous platelet gel for tissue regeneration in degenerative disorders of the knee. Blood Transfus. 2012 Jan;10 (1):72-7. Epub 2011 Oct 25.
26. Gobbi A, Karnatzikos G, Mahajan V, Malchira S. Platelet-rich plasma treatment in symptomatic patients with knee osteoarthritis: preliminary results in a group of active patients. Sports Health. 2012 Mar;4 (2):162-72.
27. Spaková T, Rosocha J, Lacko M, Harvanová D, Gharaibeh A. Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. Am J Phys Med Rehabil. 2012 May;91 (5):411-7.
28. Kon E, Mandelbaum B, Buda R, Filardo G, Delcogliano M, Timoncini A, Fornasari PM, Giannini S, Marcacci M. Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis. Arthroscopy. 2011 Nov;27 (11):1490-501. Epub 2011 Aug 10.
29. Filardo G, Kon E, Pereira Ruiz MT, Vaccaro F, Guitaldi R, Di Martino A, Cenacchi A, Fornasari PM, Marcacci M. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach. Knee Surg Sports Traumatol Arthrosc. 2012 Oct;20 (10):2082-91. Epub 2011 Dec 28.
30. ŚanchezM, Fiz N, Azofra J, Usabiaga J, Aduriz Recalde E, Garcia Gutierrez A, Albillos J, Gárate R, Aguirre JJ, Padilla S, Orive G, Anitua E. A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. Arthroscopy. 2012 Aug;28 (8):1070-8.
31. Cerza F, Carní S, Carcangiu A, Di Vavo I, Schiavilla V, Pecora A, De Biasi G, Ciuffreda M. Comparison between hyaluronic acid and platelet-rich plasma, intraarticular infiltration in the treatment of gonarthrosis. Am J Sports Med. 2012 Dec;40 (12):2822-7. Epub 2012 Oct 25.
32. Patel S, Dhillon MS, Aggarwal S, Marwaha N, Jain A. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, doubleblind, randomized trial. AmJ SportsMed. 2013 Feb;41 (2):356-64. Epub 2013 Jan 08.
33. Filardo G, Kon E, Di Martino A, Di Matteo B, Merli ML, Cenacchi A, Fornasari PM, Marcacci M. Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: study design and preliminary results of a randomized controlled trial. BMC Musculoskelet Disord. 2012;13:229. Epub 2012 Nov 23.
34. Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009 Mar;27 (3):158-67. Epub 2009 Jan 31.
35. Anitua E, Orive G, Aguirre JJ, Andiá I. Five-year clinical evaluation of short dental implants placed in posterior areas: a retrospective study. J Periodontol. 2008 Jan;79 (1):42-8.
36. Perut F, Filardo G, Mariani E, Cenacchi A, Pratelli L, Devescovi V, Kon E, Marcacci M, Facchini A, Baldini N, Granchi D. Preparation method and growth factor content of platelet concentrate influence the osteogenic differentiation of bone marrow stromal cells. Cytotherapy. 2013 Jul;15 (7):830-9.
37. Mariani E, Cattini L, Neri S, Malavolta M, Mocchegiani E, Ravaglia G, Facchini A. Simultaneous evaluation of circulating chemokine and cytokine profiles in elderly subjects by multiplex technology: relationship with zinc status. Biogerontology. 2006 Oct-Dec;7 (5-6):449-59.
38. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986 Aug;29 (8):1039-49.
39. Cavallo C, Desando G, Facchini A, Grigolo B. Chondrocytes from patients with osteoarthritis express typical extracellular matrix molecules once grown onto a threedimensional hyaluronan-based scaffold. J Biomed Mater Res A. 2010 Apr;93 (1):86-95.
40. Ahmed SA, Gogal RMJr, Walsh JE. A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay. J Immunol Methods. 1994 Apr 15;170 (2):211-24.
41. Blanco FJ, Geng Y, Lotz M. Differentiation-dependent effects of IL-1 and TGFbeta on human articular chondrocyte proliferation are related to inducible nitric oxide synthase expression. J Immunol. 1995 Apr 15;154 (8):4018-26.
42. Martin I, Jakob M, Schäfer D, Dick W, Spagnoli G, Heberer M. Quantitative analysis of gene expression in human articular cartilage from normal and osteoarthritic joints. Osteoarthritis Cartilage. 2001 Feb;9 (2):112-8.
43. David-Raoudi M, Deschrevel B, Leclercq S, Galéra P, Boumediene K, Pujol JP. Chondroitin sulfate increases hyaluronan production by human synoviocytes through differential regulation of hyaluronan synthases: role of p38 and Akt. Arthritis Rheum. 2009 Mar;60 (3):760-70.
44. Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent. 2001;10 (4):225-8.
45. Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. 2004 Apr;62 (4):489-96.
46. Creaney L, Hamilton B. Growth factor delivery methods in the management of sports injuries: the state of play. Br J Sports Med. 2008 May;42 (5):314-20. Epub 2007 Nov 05.
47. McCarrel TM, Minas T, Fortier LA. Optimization of leukocyte concentration in platelet-rich plasma for the treatment of tendinopathy. J Bone Joint Surg Am. 2012 Oct 3;94 (19):e143-8: 1-8).
48. Moojen DJ, Everts PA, Schure RM, Overdevest EP, van Zundert A, Knape JT, Castelein RM, Creemers LB, Dhert WJ. Antimicrobial activity of platelet-leukocyte gel against Staphylococcus aureus. J Orthop Res. 2008 Mar;26 (3):404-10.
49. Bielecki TM, Gazdzik TS, Arendt J, Szczepanski T, Król W, Wielkoszynski T. Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: an in vitro study. J Bone Joint Surg Br. 2007 Mar;89 (3):417-20.
50. Bryan N, Ahswin H, Smart N, Bayon Y, Wohlert S, Hunt JA. Reactive oxygen species (ROS) - a family of fate deciding molecules pivotal in constructive inflammation and wound healing. Eur Cell Mater. 2012;24:249-65. Epub 2012 Sep 24.
51. Batten ML, Hansen JC, Dahners LE. Influence of dosage and timing of application of platelet-derived growth factor on early healing of the rat medial collateral ligament. J Orthop Res. 1996 Sep;14 (5):736-41.
52. Torricelli P, Fini M, Filardo G, Tschon M, Pischedda M, Pacorini A, Kon E, Giardino R. Regenerative medicine for the treatment of musculoskeletal overuse injuries in competition horses. Int Orthop. 2011 Oct;35 (10):1569-76. Epub 2011 Mar 11.
53. Weibrich G, Hansen T, KleisW, Buch R, Hitzler WE. Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration. Bone. 2004 Apr;34 (4):665-71.
54. Kon E, Filardo G, Delcogliano M, Fini M, Salamanna F, Giavaresi G, Martin I, Marcacci M. Platelet autologous growth factors decrease the osteochondral regeneration capability of a collagen-hydroxyapatite scaffold in a sheep model. BMC Musculoskelet Disord. 2010;11:220. Epub 2010 Sep 27.
55. Anitua E, Sánchez M, Zalduendo MM, de la Fuente M, Prado R, Orive G, Andiá I. Fibroblastic response to treatment with different preparations rich in growth factors. Cell Prolif. 2009 Apr;42 (2):162-70. Epub 2009 Feb 24.
56. Boswell SG, Cole BJ, Sundman EA, Karas V, Fortier LA. Platelet-rich plasma: a milieu of bioactive factors. Arthroscopy. 2012 Mar;28 (3):429-39. Epub 2012 Jan 28.
57. Fortier LA, Lust G, Mohammed HO, Nixon AJ. Coordinate upregulation of cartilage matrix synthesis in fibrin cultures supplemented with exogenous insulin-like growth factor-I. J Orthop Res. 1999 Jul;17 (4):467-74.